Discover the Coolest Innovationsin Cardiac Ablation Technology

PURPOSE-BUILT SOLUTION FOR VENTRICULAR TACHYCARDIA

Adagio's proprietary Ultra Low Temperature Cryoablation (ULTC) technology is designed to produce large, durable, lesions extending through the depth of both diseased and healthy cardiac tissue. The Company's vClas™ ULTC catheter to treat VT received CE Mark based on the safety and effectiveness data from the CRYOCURE-VT study. The product is currently being evaluated in the FULCRUM-VT Pivotal IDE study in the U.S.

CLINICAL STUDIES
see more >

PEER-REVIEWED PUBLICATIONS
see more >

COMPANY NEWS
see more >

SCIENTIFIC PRESENTATIONS
see more >

A NEW PARADIGM IN VT ABLATIONS

• Large, durable lesions of titratable depth (>10 mm)
• Endocardial ablations of mid-myocardial scar
• Catheter stability during energy delivery
• Time and effort efficient procedures with few lesions
• No catheter irrigation simplifies hemodynamic management in HF patients

Learn more about Adagio's VT Cryoablation System with vClas™ catheter ...